is mounjaro a glp-1 agonists Ophthalmic Complications Observed After Use of GLP-1 agonists approved for clinical

It is possible that the transient worsening of DR can be explained by the rapid drop in hemoglobin A1c levels

Vrktjer som tabs- og indsatsgrnser, realitetstjek, sessionstidsml og let adgang til selvudelukkelse er essentielle

Efficacy and safety of liraglutide versus placebo as add-on to glucose-lowering therapy in patients with type 2 diabetes and moderate renal impairment (LIRA-RENAL): a randomized clinical trial

According to OECD, obesity rates vary significantly, reaching 22.1% in Brunei Darussalam and 17.8% in New Zealand

The critical role of underlying coronary artery disease (CAD) in the pathogenesis of AF and ventricular fibrillation should not be overlooked

This study also showed a non-significant 17% reduction in albuminuria.67 The AWARD-7 study analyzed the efficacy of dulaglutide in patients with DM2 and moderate-severe CKD (mean eGFR 38 ml/min/1.73 m2)